Form D · Biotechnology
Regenerative Medical Solutions, Inc.
Madison, WI · CIK 0001579613
Offering snapshot reported Aug 28, 2023 · SEC filing
- Reported sold
- $5M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 28, 2023 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
| Aug 14, 2018 | Initial | $181,000 | No comparison | 1 | SEC filing |
| Nov 7, 2014 | Initial | $375,000 | No comparison | 1 | SEC filing |
| Jul 18, 2014 | Amendment | $595,000 | $0vs Feb 10, 2014 | 9 | SEC filing |
| Feb 10, 2014 | Initial | $595,000 | No comparison | 9 | SEC filing |
| Jun 20, 2013 | Initial | $850,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490794
Source: Form D, filed Aug 28, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Gorman | Director |
| Thomas Joyce | Executive |
| Anthony D. Kolton | Director, Executive |
| Jon S. Odorico, Md, Facs | Director |
| Guy Tagliavia | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
505 S. Rosa Road, #26
Madison, WI, 53719
Madison, WI, 53719